ABL is pleased to announce the immediate available of two new DeepChek® Assays intended to be used for:
- Determining antiviral drug resistance to cidofovir, foscarnet sodium, ganciclovir and maribavir in patients infected with cytomegalovirus (CMV) – DEEPCHEK®-CMV UL54/UL97 ASSAY
- Determining drug resistance to isoniazid and rifampicin in patients infected with TB – DEEPCHEK®-TB RPOB/INHA GENOTYPING ASSAY